Gumshoe Articles: Biotech/Medical

What's the pre-IPO story about a "$2 Billion Cannabis Deal About to Go Down on the Las Vegas Strip" being teased by Cannabis Venture Syndicate?

Doc Gumshoe looks at testing, herd immunity, and a few updates in diabetes and lung cancer

Checking into a teased anti-obesity drug that's not yet in the "mainstream headlines"

Updates on some healthcare and real estate stocks in the Real Money Portfolio, including four add-on buys and two new names for the watchlist

What's being touted by Money Morning in ads for Michael Robinson's new Bio-Technology Profit Alliance?

Doc Gumshoe on "a few encouraging items"

Checking out the teaser pitch from Biotech Millionaire

Ads for Nexus-9 tease that "Over 70 firms are racing to produce the most critical vaccine of all time. But only one of them can give you a shot at making 3,000%." So... who is it?

New ad drops Kevin O'Leary's name as an early investor, and promises "Three Magic Molecule Picks for Quadruple-Digit Gains” ... so what are they?

I feel very cautious, yet also bought four new positions this week in the Real Money Portfolio...

What's Tim Bohen teasing as having huge potential and a November 7 August 7th announcement?

Some updates from Doc Gumshoe on Hydroxychloroquine, Aspirin for cancer, stem cells for Parkinson's and CRISPR for blindness

What's being teased in the ads for Mauldin's new Healthy Returns newsletter? Editor Chris Wood says, "It’s not a penny stock or risky startup. FDA approval of its blockbuster new drug is just a few short months away—and this one investment alone could hand you a small fortune in 2020."

What's teased as the latest Alzheimer's Disease recommendation from Dave Lashmet for Stansberry's Investment Advisory?